# Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk

> **NCT00317707** · PHASE3 · COMPLETED · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 12513 (actual)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** N-3 Polyunsaturated Fatty Acids
- **DRUG:** Placebo: Olive oil

## Key facts

- **NCT ID:** NCT00317707
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 12513 (ACTUAL)
- **Last updated:** 2012-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317707, "Risk and Prevention Study: Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00317707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*